Bacterial glycoprotein antigens for vaccine development
Intellectual Property
The intellectual property behind GlyProVac ApS includes:
The YghJ antigen
EP3359559A1: GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC), Granted and issued in Germany, France, Italy, Great Britain, Belgium and Denmark
US20180282379A1: Glycosylated yghj polypeptides from enterotoxigenic escherichia coli (etec), Pending
The BEMAP method
US 10,647,749 B2: GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC), Granted